Odisha Pharma Summit 2025 on December 16; policy launch, parks expected

Published On 2025-12-15 13:11 GMT | Update On 2025-12-15 13:11 GMT

Bhubaneswar: The Odisha government is all set to host the Odisha Pharma Summit 2025 on December 16, bringing together stakeholders from the pharmaceutical and medical devices sectors to explore new growth opportunities.

Chief Minister Mohan Charan Majhi is scheduled to inaugurate the summit, during which the state government would launch the Odisha Pharmaceutical and Medical Devices Policy 2025.

The new policy aims to attract investments, improve ease of doing business, and create large-scale employment opportunities in the life sciences sector, he said.

On this occasion, the government is also expected to announce development of a Pharmaceutical Park and a Medical Devices Park to strengthen the state’s healthcare manufacturing infrastructure and promote industry growth, they said.

The event will also witness the signing of MoUs between the government and leading companies, marking a significant step towards strengthening the state’s pharmaceutical and medical devices ecosystem, PTI reported.

Industries Minister Sampad Chandra Swain said, “Odisha welcomes all pharma, medical devices & related sector industries, investors, and thought leaders to join us at this summit. We are committed to building a strong, future-ready ecosystem that supports growth, innovation, and global competitiveness.”

The government invites all healthcare and industry enthusiasts to participate in this important initiative toward shaping the future of the sector in the state, he said.

Read also: Upcoming Una Bulk Drug Park receives environmental clearance

Article Source : With inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Odisha Pharma Summit 2025 on December 16; policy launch, parks expected

Similar News

Over 17000 Jan Aushadhi Kendras opened nationwide till November 30: Minister tells Parliament

Telangana: Rs 5.82 lakh worth of drugs seized from unlicensed premises at Fertility Centre

Biocon Chief Kiran Mazumdar-Shaw wins USC Business Management Award

Complaints on Jan Aushadhi medicines can be filed via CPGRAMS, email or helpline: Minister

Biocon unveils Liraglutide for diabetes, obesity in Netherlands

Judicious use of AI can be boon for healthcare pharma sectors: Dr Jitendra Singh

Biocon Biologics signs settlement, license agreement to commercialize biosimilar Aflibercept worldwide